Sumitomo Dainippon Pharma Co. Ltd.
(OTC: SMDPY)
|
6:34 PM UTC, 05/22/24 | |||
---|---|---|---|---|
Last: $1.99 | Change: -0.10 | %Change: -4.78% | Volume: 300 |
Open: | $ 1.99 | Volume: | 300 | |
---|---|---|---|---|
High: | $ 1.99 | Yield(%) | 0.00 | |
Low: | $ 1.99 | P/E Ratio (ttm): | n/a | |
Dividend ($): | 0.03 | Market Cap ($): | 826.36M | |
EPS ($) | -5.41 | Shares Out: | 397.29M |
% Price Change (last 4 weeks): | -3.93 |
---|---|
% Price Change (last 13 weeks): | -21.36 |
% Price Change (last 26 weeks): | -35.20 |
% Price Change (last 52 weeks): | -53.15 |
% Price Change (year to date): | -36.00 |
Return on Equity (%): | -106.58 |
---|---|
Return on Assets (%): | -30.00 |
Return on Invested Capital (%): | -9.99 |
Gross Profit Margin (%): | 49.94 |
---|---|
Net Profit Margin (%): | -100.13 |
Operating Profit Margin (%): | -0.47 |
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $3.29 |
52-wk low: | $1.99 |
Bid: | $n/a |
Ask: | $n/a |
Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment manufactures and sells generic and prescription drugs in Japan, North America, China, and other overseas countries. The Other Business segment division includes food ingredients, additives, chemical products, veterinary drugs, and diagnostic reagents. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.
|
Sumitomo Dainippon Pharma Co. Ltd.
2-6-8 Dosho-machi Chuo-Ku Osaka OS 541-0045 Phone: 81.6.6203.5321 Fax: 81.6.6202.6028 http://www.sumitomo-pharma.co.jp |
Earnings (1year) ($): | -5.41 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 2.60 |
Cash Flow ($): | -4.83 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 0.45 |
Price/Book (x): | 0.95 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 0.30 |
---|---|
Current Ratio (x): | 0.52 |
LT Debt/Equity (x): | 88.79 |
Total Debt/Equity (x): | 274.16 |